Related Experiment Videos
Childhood anemia in Africa: to transfuse or not transfuse?
B R Holzer1, M Egger, T Teuscher
1St. Francis Designated District Hospital, Ifakara, Kilombero, Tanzania.
Insights
Blood transfusions for childhood anemia in high HIV prevalence areas showed similar packed cell volume (PCV) levels compared to no transfusion. Further research is needed to weigh the risks and benefits of transfusions in these regions.
Area of Science:
- Public Health
- Infectious Diseases
- Pediatrics
Background:
- Blood transfusions are a significant transmission route for Human Immunodeficiency Virus (HIV) in Africa.
- Childhood anemia is prevalent in holoendemic malaria regions, often managed with blood transfusions.
Purpose of the Study:
- To evaluate the necessity and impact of blood transfusions in managing childhood anemia in a high HIV prevalence setting.
- To compare packed cell volume (PCV) levels and clinical outcomes in anemic children receiving transfusions versus those treated with medication alone.
Main Methods:
- A randomized trial involving 116 children with anemia in Ifakara, Tanzania.
- Participants were assigned to receive either malaria and hookworm treatment alone or with the addition of HIV-screened whole blood transfusion.
- Packed cell volume (PCV) was measured at admission, 2 days, 4 weeks, and 8 weeks post-entry.
Main Results:
- Mean PCV at admission was comparable between the transfusion (14.0%) and no transfusion (14.4%) groups.
- After 8 weeks, PCV levels were similar in both groups (22.9% vs. 23.6%).
- A trend towards increased hospital admissions and deaths was observed in the no transfusion group, though confidence intervals were wide.
Conclusions:
- Blood transfusions did not significantly improve PCV levels in anemic children compared to standard treatment in this study.
- The potential benefits and risks of blood transfusions, particularly concerning HIV transmission, require careful consideration in policy-making.
- A larger randomized trial is essential to definitively assess the cost-benefit ratio and safety of blood transfusions for childhood anemia in high HIV prevalence areas.
Abstract:
Blood transfusions are an important route for HIV transmission in Africa. To explore whether transfusions are necessary in the case management of childhood anemia, a randomized trial was performed in Ifakara, Tanzania, a holoendemic malaria region. 116 children were randomized to receive either treatment for malaria and hookworm alone or, in addition, a transfusion of whole blood which had been tested negative for antibodies against the human immunodeficiency virus. Mean packed cell volume (PCV) at admission was 14.0% in the transfusion and 14.4% in the no transfusion group. Children were followed up for 8 weeks with measurements of PCV at 2 days, 4 weeks and 8 weeks after study entry. PCV was similar in both groups after 4 and 8 weeks (22.9% in the transfusion and 23.6% in the no transfusion group). There was a trend towards more hospital admissions and deaths in the no transfusion group; however, 95% confidence intervals included both a beneficial and an adverse effect of blood transfusions. The costs and benefits of transfusion for childhood anemia in countries with a high HIV prevalence need to be considered carefully before a rational treatment policy can be adopted. For that purpose, a larger randomized trial is urgently needed.